The Global Alliance for Progress (GAP) Program is the WFH flagship development program aimed at closing the gap in treatment between developed and developing countries. Today’s session will cover many interesting topics, including a vision for sustainable national hemophilia care programs; a framework for collaboration and support; country experiences from Algeria, Brazil and Serbia; and a look towards the future of GAP.
Time and place: 14:15 to 15:45 at the Product/Showcase Theatre in the Exhibit Hall of the Scottish Event Campus.
The GAP Program is supported by funding from: Bayer, Biotest, CSL Behring, Kedrion, Pfizer, Sanofi Genzyme, Shire, and SOBI. The WFH would also like to thank the World Health Organization for its support of the Program.